London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Stated to an answer in line with expectations for 2024...dyor etc
He is a safe cautious investor not a major risk taker happy to tke his time its a steady slow safe style take it or leave it
I am involved in another IP rich, commercially sensitive, partner roll out model type business.
That team has no issue providing 3 year forecasts, detail and less of the ''we can't possibly go into that.''
There seems to be a distinct aroma of mutton around today.
Just heard that from CEO
Now we are talking
Because only institutions realy make sp move
The share price you muppet Barder is crucial. It is your job to execute to move the share price.
He is way too blase.
Very disappointed that it seems there's no plan to launch Eroxon in the US this year. I'm also concerned that the EU patent protection for Eroxon may not be robust for all markets.
I'm out, for now anyway..
Okay got the 350m question wrong - that is what the sales will be and not what fum will make...maybe I need to wake up...lol
and of course they cannot answer the question on how much they will make
Why have they not give an indication of revenue /sales forecast for 2024? We are now pretty much in all key EU markets as well as Saudi ( zero feedback on that one considering it is one of the most lucrative markets) and yet no forecast pathetic IMO! Get rid of that CFO who’s it is to forecast these things useless!
WOW... 13% down this morning Barder needs to wake up , stop looking out of the window and show some enthusiasm.
Currently listening to the presentation and find it a waste of time, as every question they say they cannot answer....
also find Barder really doesn't seem to want to be there, more intrested in lookin out the window....
although they say they should make about 350m from the US, according to an IPSOS review (think I got that right)
" on the path towards profitability in the next 12 months."
Careful choice of words.
Could mean anything.
Rpg7
"too many characters with nanosecond attention spans who need instant gratification ."
Im sure that could mean anyone but for myself, I have traded since 2001. I am more than experinced with how markets over react or sell on the news, or no news in this case. I have only been in this 3 years but I class it more than a nano second. Excuse any blunt tones. I am sure we will have our day in the sun but I must say was hardly worth waking up for early this morning.
I am also disappointed, but if the management are so weak (no opinion) then this will become a takeover target with a good premium. I am going to buy more.....
The markets are abysmal, too many characters with nanosecond attention spans who need instant gratification .
"Why put a negative spin on it?"
I think I have been balanced. If you read all my posts this morning. I am not going out of my way to see anything negative. Unlike the markets.
I found the RNS to be underwhelming. The only thing tangible is the 3.1m revenue and 20% of market share. The later was fed to us in the last RNS. The rest is just talking up what we already know.
I do like the talk on ensuring to build up supply lines. But surely this is more of tasking for Coopers/Haleon etc.
I remain largly optimistic in the medium term and no intention of selling.
Those INVESTED here are buying into a firm with a proven product, an enormous global market, quality distributors, BUT also in the EARLY GROWTH phase. There will be wobbles (on presentational aspects) and the Board will test (and fail) different approaches, however, the commercial pathway is increasingly clear with prospects of a life-changing capital event.
I'm not concerned on market overreaction ('sell on the news' - not exactly uncommon) and not making any fatuous predictions on SP, short, medium or long. I do, however, remain hopeful that it will pay off my enormous mortgage one day!!!
ATB LTH's.
Comek2, rather than having a rant at Buffaloben perhaps you shoukd be asking why the market has marked FUM down by almost 15%.
What a story we have to tell. But do you really think that story is well told? FUM's RNSs have a tendency to underwhelm the market, just like today.
Same here. I puked out a lot of stock at a loss recently as Barder is useless.
I will now exit completely and revisit down the line.
Very disappointed, as this game changing product and its investors deserve a quality team to maximise the oportunity.
Well, our out of depth ‘lite’ management team never fails to disappoint. We have a media shy CEO and a CFO who is not a qualified accountant so this was always going to be a high risk play. Great product, poor execution. My fear is that our weak CFO has given too much away on the margins but it is impossible to tell as we receive little or no financial data with which to calculate. Despite urging Barder to strengthen the team we bring in a NED who works one day a week. Who would sign a commercial deal for US in June 2023 and allow it to drift for so long leaving the uncertainty to hang over the share price? Again, inexperience has caught them out. I will say it again, we need commercially savvy, proven commercial executives with experience of FMCG. IMO Barder does not have the courage to bring others in who will make him and CFO weak. So much potential but the market can see the weakness. I sold half of my holding months ago when I did not receive satisfactory answers from Barder. See you next year!
My understanding is that the accumulated losses must be cleared which requires profits of £67.3m + tax on the profits. There are also currently 301m shares +20m options so a one penny / share dividend will require a further £3.2m profit + tax in order to pay it. It may take more than a year to achieve this.
Buffaloben are you for real? The “going concern” is a requirement by the stock market regulation for every company announcement in its update. 1st revenues and profits and 20% market share for a small company, profitability in 2024 and 2025, 7m in the coffers while marketing and distributions cost met by distributors, foray into the Middle East and Latin America after Europe and the USA. Why put a negative spin on it?
AIM 'investors' in particular are notoriously impatient. A great many PIs are much closer to gamblers than they are investors. The U.S. and Haleon continue to be the golden ticket here for me. Happy to hold through this period and may accumulate a few more as the short-termers start selling out.
The presentation won't help much.
These guys can't market for anything. They need a branding and awareness team.
?